Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
09/2006
09/13/2006EP1699752A1 (hetero)cyclyl carboxanilides for controlling harmful fungi
09/13/2006EP1419148B1 M-aminophenol derivatives and colouring agents containing them
09/13/2006EP1406869B1 Taxol enhancer compounds
09/13/2006EP1286944B1 A solvent exchange process
09/13/2006EP0917462B1 Cell adhesion inhibitors
09/13/2006CN1830972A Y-type second-order non-linear optical luminophor contg. triphenylamine, prepn. method and use thereof
09/13/2006CN1830952A Process for preparing intermediate of citalopram
09/13/2006CN1830551A Production technology of tetrahydrofururyl alcohol and its catalyst
09/13/2006CN1275101C Electric photographic photoreceptor, imaging processing cartidge and electric photographic device
09/13/2006CN1274690C Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient
09/13/2006CN1274688C Synthesis method of 5-hydroxy methyl furazolidone
09/13/2006CN1274683C Ketone compound and its preparation method and application
09/13/2006CN1274672C Aminoacetonitrile derivatives and their use for controlling parasites
09/13/2006CN1274670C Diaminopropionic acid derivatives
09/13/2006CN1274382C Ionic liquids as selective additives for separation of close-boiling or azeotropic mixtures
09/12/2006US7105707 By reacting an aryl nitrile with an alkynylzinc compound, a bis-alkynylzinc compound, or an alkynylmagnesium compound, in the presence of a nickel/phosphine catalyst.
09/12/2006US7105702 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation
09/12/2006US7105684 Lactone compounds
09/12/2006US7105671 2-Substituted phenyl,3-polar ring,N-heroaromatic propion-amides, e.g., 1-(2-(3,4-Dichlorophenyl)-3-(tetrahydro-furan-2-yl)-propionyl)-3- methylurea; antidiabetic agents; increase the flux of glucose metabolism in beta-cells and hepatocytes
09/12/2006US7105568 Compounds for treatment of cardiac arrhythmia and methods of use
09/12/2006US7105564 7-(3-{[5-(Pyrrole-1-sulfonyl)-thiophene-2-carbonyl]-amino}-bicyclo[2.2.1]hept-2-yl)-hept-5-enoic acid; thromboxane A2 receptor and a prostaglandin D2 receptor; for all of eosinophilic infiltration, advance of respiratory anaphylaxis and respiratory contraction
09/12/2006US7105559 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
09/12/2006US7105471 Arylphenyl-substituted cyclic ketoenols
09/12/2006CA2140929C Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
09/11/2006CA2500676A1 Preparation of acid addition salts of amine bases by solid phase-gas phase reactions
09/08/2006WO2006092893A1 Enterokinesis promoting compound
09/08/2006WO2005117907A3 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
09/07/2006US20060199856 Dihydroorotate dehydrogenase (DHODH) inhibitors; Rheumatoid arthritis, Pneumocystis carinii, fibrosis, uveitis, rhinitis, asthma, and athropathy; 2-(Biphenyl-4-ylcarbamoyl)-cyclopent-1-enecarboxylic acid
09/07/2006US20060199826 Cyclopropane compounds and pharmaceutical use thereof
09/07/2006US20060199822 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
09/07/2006US20060199783 Anti-Hepatitis c nucleosides containing 2-deoxy-2-fluoro-2-C-methyl- beta -D-ribofuranosyl nucleosides from a naturally-occurring nucleoside; Ethyl trans-2,3-dideoxy-4,5-O-isopropylidene-2-C-methyl-D-glycero-pent-2-enonate
09/07/2006DE102005009473A1 Mehrlagen-Katalysator zur Herstellung von Phthalsäureanhydrid Multi-layer catalyst for producing phthalic anhydride
09/06/2006EP1698629A2 Polyamines and their use in therapy
09/06/2006EP1698620A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions
09/06/2006EP1698618A1 Benzamide derivative
09/06/2006EP1697337A2 Ornithine derivatives as prostaglandin-e2-agonists or antagonists
09/06/2006EP1697336A2 Aroylfuranes and aroylthiophenes suitable for the treatment of cancer
09/06/2006EP1697335A1 Furancarbonylguanidine derivatives, their preparation and pharmaceutical compositions containing them
09/06/2006EP1636162B1 Method for producing phthalic anhydride
09/06/2006EP1423357B1 Urea derivatives with antiproteolytic activity
09/06/2006EP1303308B1 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
09/06/2006CN1829711A Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
09/06/2006CN1829697A Aryl-heteroaromatic products, compositions containing same and use thereof
09/06/2006CN1827621A Novel derivatives and analogues of galanthamin
09/06/2006CN1827611A Process for preparing 3,3',4,4'-tetracarboxydiphthalic ether dianhydride
09/06/2006CN1273460C Benzofuran and benzothiophene derivatives
09/06/2006CN1273459C Process for preparing lactones
09/06/2006CN1273458C Method for purifying tetrahydrofuran by distillation
09/06/2006CN1273444C Dipeptide nitriles
09/06/2006CN1273432C Method for optically and selectively epoxidizing alkenone compound
09/05/2006USRE39263 2-2-fluoro-5-ethylsulphonylamino-4-thiocarbamoyl-phenyl)-5,6,7,8-tetrahydro-1,2,4triazolo[4,3-a]pyridin-3(2H)-one; post or preemergent
09/05/2006US7102027 Adamantanetricarboxylic acid derivatives
09/05/2006US7102019 Cosmetic and pharmaceutical preparations comprising ascorbic acid derivatives
09/05/2006US7102018 Such as 2-(t-butyldimethylsilyloxymethyl)-3,4-((dimethylmethylene)-dioxy)-5-hydroxy -tricyclo(5.2.1.02,6)deca -3,8-diene; for Diels-alder reaction; antitumor agents
09/05/2006US7101915 P-terphenyl compounds
09/05/2006US7101912 when co-administered with levodopa in the colon of a patient is taken up at a much higher bioavailability than levodopa alone; treating Parkinson's disease or hypertension; dosage forms; sustained release; oral administration
09/05/2006US7101895 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors
09/05/2006US7101878 Non-peptide GNRH agents, methods and intermediates for their preparation
09/05/2006US7101871 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
09/05/2006US7101867 Benzofuran derivatives, their production and use
08/2006
08/31/2006WO2006090921A1 Inhibitory effect of sulfonamide compound on lymphocyte activation
08/31/2006WO2006090920A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR ACTIVATING RECEPTOR δ
08/31/2006WO2006090409A1 An improved process for the preparation of 5 - carboxyphthalide
08/31/2006WO2005051937A8 4-oxo-4,5-dihydro-furan-2-carboxylic and acid derivatives and methods of treatment of metabolic-related disorders thereof
08/31/2006US20060194872 Diamine derivative, production process therefor and antioxidant
08/31/2006US20060194851 Benzofuran compound and medicinal composition containing the same
08/31/2006US20060194825 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
08/31/2006US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma
08/31/2006US20060194816 Benzofuran derivatives useful for treating hyper-proliferative disorders
08/31/2006US20060194772 Triamide-substituted heterobicyclic compounds
08/31/2006DE112004001667T5 Polymer-Komplex-Verbindung und Licht emittierendes Polymerbauteil, das dieselbe verwendet Polymer complex compound and polymer light-emitting device that uses the same
08/31/2006CA2599454A1 Activator for peroxisome proliferator activating receptor d
08/30/2006EP1695971A1 Substituted phenyl-piperazine compounds, their preparation and use in medicaments
08/30/2006EP1695959A1 Compouds and methods for the inhibition of the expression of VCAM-1
08/30/2006EP1695705A1 Compounds effecting glucokinase
08/30/2006EP1694663A1 Novel benzofuran derivatives, which can be used in prophylaxis or treatment of 5-ht6 receptor-related disorder
08/30/2006EP1694662A2 Method for the production of defined mixtures of thf, bdo and gbl by gas phase hydrogenation
08/30/2006EP1694661A1 Process for the production of ethers
08/30/2006EP1694642A2 Mutagenic heterocycles
08/30/2006EP1694641A2 Prostaglandin synthesis
08/30/2006EP1694640A1 Anti-cancer agents
08/30/2006EP1694638A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
08/30/2006EP1694627A2 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics
08/30/2006EP1694438A1 Catalyst extrudates based on copper oxide and their use for hydrogenating carbonyl compounds
08/30/2006EP1694410A2 Cyclopropane compounds and pharmaceutical use thereof
08/30/2006EP1487813B1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
08/30/2006EP1202953B1 Substituted 2-dialkylaminoalkylbiphenyl derivatives
08/30/2006EP1020439B1 Cetp activity inhibitors
08/30/2006EP0994100B1 3-anilino-2-cycloalkenone derivates
08/30/2006CN1826330A Combretastatin derivatives with cytotoxic action
08/30/2006CN1826316A Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them
08/30/2006CN1826310A Novel aminobenzophenone compounds
08/30/2006CN1823758A Compounds and methods of treating transplant rejection
08/30/2006CN1272330C Compound 4-methoxy-7-methyl-3-oxo-1,3-dihydro isophenol furan-5-formaldehyde and its preparing method
08/30/2006CN1272324C Novel herbicides
08/30/2006CN1272322C Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
08/29/2006US7098365 [4-{2-[(2-hydroxy-benzylidene)-amino]-ethyl}-phenol]; plant growth regulator
08/29/2006US7098349 Continuous process for producing tetrahydrofuran by catalytic reaction of butanediol/1,4-/ with heteropolyacid catalyst
08/29/2006US7098348 Immunosuppressants and apoptosis for cells for anticancer agents
08/29/2006US7098215 Nitrogenous compounds and antiviral drugs containing the same